Experts in oncology emphasize the pivotal role of precision medicine in revolutionizing cancer treatment. According to Jatin Shah and Mrinal Gounder from Memorial Sloan Kettering Cancer Centre, individualized approaches tailored to each patient’s unique biology are the future of cancer care. This paradigm shift acknowledges that no two cancers, or individuals, are alike.
With advancements in surgery, radiation, chemotherapy, and genetic profiling, precision medicine aims to deliver targeted therapies for optimal outcomes. Immunotherapy, particularly its evolving iterations like Immunotherapy 2.0, represents the next frontier in cancer treatment. While immunotherapy has shown promise in curing some patients, ongoing research focuses on understanding why it may not be effective for others, driving innovation towards more personalized and effective treatment strategies.